These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 33081905)
21. Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers. Danser AHJ; Epstein M; Batlle D Hypertension; 2020 Jun; 75(6):1382-1385. PubMed ID: 32208987 [TBL] [Abstract][Full Text] [Related]
22. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Guo YR; Cao QD; Hong ZS; Tan YY; Chen SD; Jin HJ; Tan KS; Wang DY; Yan Y Mil Med Res; 2020 Mar; 7(1):11. PubMed ID: 32169119 [TBL] [Abstract][Full Text] [Related]
23. Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic. Brufsky A J Med Virol; 2020 Jul; 92(7):770-775. PubMed ID: 32293710 [TBL] [Abstract][Full Text] [Related]
24. Fighting the Host Reaction to SARS-COv-2 in Critically Ill Patients: The Possible Contribution of Off-Label Drugs. Scala S; Pacelli R Front Immunol; 2020; 11():1201. PubMed ID: 32574268 [TBL] [Abstract][Full Text] [Related]
25. Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients. Wang C; Xie J; Zhao L; Fei X; Zhang H; Tan Y; Nie X; Zhou L; Liu Z; Ren Y; Yuan L; Zhang Y; Zhang J; Liang L; Chen X; Liu X; Wang P; Han X; Weng X; Chen Y; Yu T; Zhang X; Cai J; Chen R; Shi ZL; Bian XW EBioMedicine; 2020 Jul; 57():102833. PubMed ID: 32574956 [TBL] [Abstract][Full Text] [Related]
26. ACE2 and COVID-19 and the resulting ARDS. Zhang X; Li S; Niu S Postgrad Med J; 2020 Jul; 96(1137):403-407. PubMed ID: 32522846 [TBL] [Abstract][Full Text] [Related]
27. [Structure of SARS-CoV-2 and treatment of COVID-19]. Chen HX; Chen ZH; Shen HH Sheng Li Xue Bao; 2020 Oct; 72(5):617-630. PubMed ID: 33106832 [TBL] [Abstract][Full Text] [Related]
28. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial. Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611 [TBL] [Abstract][Full Text] [Related]
29. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB. Rico-Mesa JS; White A; Anderson AS Curr Cardiol Rep; 2020 Apr; 22(5):31. PubMed ID: 32291526 [TBL] [Abstract][Full Text] [Related]
30. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19. Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158 [TBL] [Abstract][Full Text] [Related]
31. The Immune Response and Immunopathology of COVID-19. Mortaz E; Tabarsi P; Varahram M; Folkerts G; Adcock IM Front Immunol; 2020; 11():2037. PubMed ID: 32983152 [TBL] [Abstract][Full Text] [Related]
32. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H Elife; 2020 Apr; 9():. PubMed ID: 32338605 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial. Villar J; Añón JM; Ferrando C; Aguilar G; Muñoz T; Ferreres J; Ambrós A; Aldecoa C; Suárez-Sipmann F; Thorpe KE; Jüni P; Slutsky AS; Trials; 2020 Aug; 21(1):717. PubMed ID: 32799933 [TBL] [Abstract][Full Text] [Related]
34. The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast. Almerie MQ; Kerrigan DD Med Hypotheses; 2020 Oct; 143():109883. PubMed ID: 32492562 [TBL] [Abstract][Full Text] [Related]
35. Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application. Soto ME; Guarner-Lans V; Soria-Castro E; Manzano Pech L; Pérez-Torres I Medicina (Kaunas); 2020 Jul; 56(8):. PubMed ID: 32752010 [TBL] [Abstract][Full Text] [Related]